Assessment of Future Scientific Needs for Live Variola Virus
National Academies Press, Apr 30, 1999 - Medical - 105 pages
In 1980, the World Health Organization (WHO) officially declared that smallpox had been eradicated. In 1986, WHO's international Ad Hoc Committee on Orthopox Virus Infections unanimously recommended destruction of the two remaining official stocks of variola virus, one at the Centers for Disease Control and Prevention and the other at the VECTOR laboratory in Siberia. In June 1999, WHO decided to delay the destruction of these stocks. Informing that decision was Assessment of Future Scientific Needs for Variola Virus, which examines:
-- Whether the sequenced variola genome, vaccinia, and monkey pox virus are adequate for future research or whether the live variola virus itself is needed to assist in the development of antiviral therapies.
-- What further benefits, if any, would likely be gained through the use of variola in research and development efforts related to agent detection, diagnosis, prevention, and treatment.
-- What unique potential benefits, if any, the study of variola would have in increasing our fundamental understanding of the biology, host-agent interactions, pathogenesis, and immune mechanisms of viral diseases.
What people are saying - Write a review
We haven't found any reviews in the usual places.
Development of Antiviral Agents
Development of Vaccines
6 other sections not shown
Other editions - View all
animal models antibodies antigen antiviral agents apoptosis assays assessment biology cell culture cidofovir clinical cloned committee cowpox cytokine detection diagnosis DNA fragments drugs eradication of smallpox Esposito future scientific needs gene genetic genome global host cell human cells human immune system immune response immune system immunocompromised Immunology individuals Infectious Diseases inoculation interactions isolates laboratory lesions live vaccinia live variola virus live virus lymphocytes Medicine membrane Microbiology molecular molecules monkeypox virus monkeys National Institutes needs for live novel vaccines organs orthopoxviruses pathogen pathogenesis patients Ph.D polymerase chain reaction potency potential poxviruses produced proteins rash Recent recombinant replication require retention of live serpin skin smallpox vaccine specific strains strategies target testing therapy tion tissue culture transmission U.S. Department University vaccinia vaccine vaccinia virus variola major variola proteins variola virus genome variola virus stocks VECTOR viral proteins virions Virology virulence viruses World Health Organization